Menu
Medical Condition
Gastroenterology & Hepatology
Gastroenterology & Hepatology ICD-10: K31.8_7

Bezoar (Lactobezoar - Milk curds)

Bezoar (Lactobezoar - Milk curds) - Clinical guidelines.

Medical Disclaimer
This condition guide is intended for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider regarding any symptoms or medical conditions.

Clinical Assessment & Protocol

Typical Presentation (HPI)

EN: Patient presents with symptoms suggestive of gastric outlet obstruction, including post-prandial vomiting, abdominal distension, and irritability. History significant for recent initiation or concentration adjustment of infant formula. No history of foreign body ingestion. Symptoms correlate with feeding intervals. AR: يعاني المريض من أعراض توحي بانسداد مخرج المعدة، بما في ذلك القيء بعد الرضاعة، انتفاخ البطن، والتهيج. التاريخ المرضي يشير إلى بدء حديث أو تعديل في تركيز حليب الأطفال الصناعي. لا يوجد تاريخ لابتلاع أجسام غريبة. الأعراض تتزامن مع فترات الرضاعة.

General Examination

EN: Abdominal examination reveals visible gastric peristaltic waves, epigastric fullness, and a palpable, mobile, non-tender mass in the upper abdomen. Bowel sounds are hyperactive. Hydration status: [e.g., mucous membranes moist/dry, fontanelle status]. AR: يكشف فحص البطن عن وجود موجات حركية معدية مرئية، امتلاء في منطقة الشرسوف، وكتلة ملموسة، متحركة، وغير مؤلمة في أعلى البطن. أصوات الأمعاء مفرطة النشاط. حالة الإرواء: [مثلاً: الأغشية المخاطية رطبة/جافة، حالة اليافوخ].

Treatment Protocol

EN: Management plan: 1. Cessation of oral feeds. 2. Initiation of IV fluid resuscitation. 3. Conservative management via gastric lavage with normal saline or N-acetylcysteine if indicated. 4. Serial abdominal imaging (X-ray/US) to monitor resolution. 5. Gradual reintroduction of diluted formula upon clinical improvement. AR: خطة العلاج: 1. التوقف عن الرضاعة الفموية. 2. البدء بالتعويض الوريدي للسوائل. 3. العلاج التحفظي عن طريق غسيل المعدة بمحلول ملحي طبيعي أو "إن-أسيتيل سيستين" إذا لزم الأمر. 4. إجراء تصوير متسلسل للبطن (أشعة سينية/موجات فوق صوتية) لمراقبة زوال الكتلة. 5. إعادة إدخال الحليب المخفف تدريجياً بعد التحسن السريري.

Patient Education

EN: Lactobezoar is a mass of undigested milk curd in the stomach. Ensure proper preparation of infant formula according to manufacturer guidelines to prevent over-concentration. Monitor for signs of vomiting or abdominal discomfort. Follow up as scheduled to ensure complete resolution. AR: "لاكتوبيزوار" (كتلة الحليب) هي عبارة عن تجمع لحليب غير مهضوم في المعدة. يرجى التأكد من تحضير حليب الأطفال بشكل صحيح وفقاً لإرشادات الشركة المصنعة لتجنب التركيز الزائد. راقب ظهور أي علامات للقيء أو انزعاج في البطن. التزم بمواعيد المتابعة لضمان زوال الكتلة تماماً.

Systemic & Specialized Examinations

Cardiovascular

EN: S1, S2 present. No murmurs. Normal rate and rhythm. AR: صوتا القلب الأول والثاني طبيعيان. لا توجد نفخات.

Respiratory

EN: Lungs clear to auscultation bilaterally. AR: الرئتان صافيتان عند التسمع.

Gastrointestinal

EN: NG aspirate, endoscopy findings. AR: شفط أنفي معدي، نتائج المنظار.

Neurological

EN: Alert, oriented x3. No focal deficits. AR: المريض واعي ومدرك. لا يوجد عجز بؤري.

Dermatological

EN: Unremarkable or not routinely indicated for this specific gastrointestinal pathology. AR: طبيعي أو غير مطلوب روتينياً لهذا المرض الهضمي.

Psychiatric

EN: Unremarkable or not routinely indicated for this specific gastrointestinal pathology. AR: طبيعي أو غير مطلوب روتينياً لهذا المرض الهضمي.

OB/GYN

EN: Unremarkable or not routinely indicated for this specific gastrointestinal pathology. AR: طبيعي أو غير مطلوب روتينياً لهذا المرض الهضمي.

Ophthalmic

EN: Unremarkable or not routinely indicated for this specific gastrointestinal pathology. AR: طبيعي أو غير مطلوب روتينياً لهذا المرض الهضمي.

Dental

EN: Unremarkable or not routinely indicated for this specific gastrointestinal pathology. AR: طبيعي أو غير مطلوب روتينياً لهذا المرض الهضمي.

Orthopedic & Trauma Assessments

Mechanism of Injury

EN: Unremarkable or not routinely indicated for this specific gastrointestinal pathology. AR: طبيعي أو غير مطلوب روتينياً لهذا المرض الهضمي.

Gait & Posture

EN: Unremarkable or not routinely indicated for this specific gastrointestinal pathology. AR: طبيعي أو غير مطلوب روتينياً لهذا المرض الهضمي.

Range of Motion

EN: Unremarkable or not routinely indicated for this specific gastrointestinal pathology. AR: طبيعي أو غير مطلوب روتينياً لهذا المرض الهضمي.

Local Examination

EN: Unremarkable or not routinely indicated for this specific gastrointestinal pathology. AR: طبيعي أو غير مطلوب روتينياً لهذا المرض الهضمي.

Special Tests

EN: Unremarkable or not routinely indicated for this specific gastrointestinal pathology. AR: طبيعي أو غير مطلوب روتينياً لهذا المرض الهضمي.

Motor Power

EN: Unremarkable or not routinely indicated for this specific gastrointestinal pathology. AR: طبيعي أو غير مطلوب روتينياً لهذا المرض الهضمي.

Sensory Profile

EN: Unremarkable or not routinely indicated for this specific gastrointestinal pathology. AR: طبيعي أو غير مطلوب روتينياً لهذا المرض الهضمي.

Reflexes

EN: Unremarkable or not routinely indicated for this specific gastrointestinal pathology. AR: طبيعي أو غير مطلوب روتينياً لهذا المرض الهضمي.

Peripheral Pulses

EN: Unremarkable or not routinely indicated for this specific gastrointestinal pathology. AR: طبيعي أو غير مطلوب روتينياً لهذا المرض الهضمي.

1. Comprehensive Executive Overview: Understanding Lactobezoars

A bezoar is a tightly packed collection of partially digested or undigested material that accumulates in the gastrointestinal tract, most commonly within the stomach. When this mass is composed specifically of milk curds—typically occurring in infants fed with concentrated formula—it is clinically classified as a Lactobezoar.

In the field of pediatric gastroenterology, a lactobezoar represents a significant, albeit preventable, cause of gastric outlet obstruction. While bezoars can be categorized into various types based on their content (phytobezoars from fiber, trichobezoars from hair, pharmacobezoars from medication), the lactobezoar is unique to the neonatal and infant population. It is characterized by the precipitation of casein and fat into a solid, rubbery mass that the infant’s immature digestive system cannot break down or propel through the pylorus.

Early recognition is critical. If left untreated, a lactobezoar can progress from simple gastric distension to severe complications, including gastric ulceration, perforation, or intestinal obstruction. This guide serves as a clinical resource for understanding the mechanisms, diagnostic pathways, and therapeutic interventions required to manage this condition effectively.


2. Pathophysiology, Etiology, and Risk Factors

The Mechanisms of Formation

The formation of a lactobezoar is primarily a result of the interaction between the infant’s gastric physiology and the nutritional composition of their feed.

  • Protein Concentration: High-protein formulas, particularly those with high casein-to-whey ratios, are more prone to curdling in the acidic environment of the stomach.
  • Gastric pH: The neonatal stomach has a relatively higher pH compared to adults, but the presence of rennin (chymosin) in the infant stomach facilitates the coagulation of milk proteins.
  • Stasis: Reduced gastric motility, common in premature infants or those with underlying gastrointestinal dysmotility, allows the curdled milk to stagnate and aggregate into a cohesive mass rather than being emptied into the duodenum.

Risk Factors

The clinical profile of an infant at risk for a lactobezoar typically includes:
1. Prematurity: Low birth weight and underdeveloped gastrointestinal musculature.
2. Formula Composition: Use of high-calorie, high-protein, or inappropriately prepared concentrated formulas.
3. Feeding Practices: Rapid feeding or excessive volumes that overwhelm the infant’s gastric emptying capacity.
4. Medication Interference: Use of antacids or H2-receptor antagonists, which alter the gastric pH and may interfere with the digestive enzymes necessary for breaking down milk proteins.

Risk Factor Category Specific Clinical Driver
Nutritional High-casein formula, improper dilution
Developmental Prematurity, low gastric motility
Pharmacological Altered gastric pH (H2 blockers/PPIs)
Anatomical Gastric outlet narrowing or structural anomalies

3. Signs, Symptoms, and Clinical Presentation

The clinical presentation of a lactobezoar often mimics other neonatal gastrointestinal emergencies, such as necrotizing enterocolitis (NEC) or pyloric stenosis. Physicians must maintain a high index of suspicion.

Common Clinical Manifestations

  • Abdominal Distension: Often the first clinical sign, presenting as a tense, tympanic abdomen.
  • Vomiting: Typically non-bilious, though it may become bilious if the obstruction progresses to the small intestine.
  • Feeding Intolerance: The infant may show signs of distress during or after feeding, including arching, irritability, or refusal to feed.
  • Palpable Mass: In thin infants, a firm, mobile mass may be palpable in the epigastric region during physical examination.
  • Respiratory Distress: Severe gastric distension can push the diaphragm upward, leading to tachypnea and decreased oxygen saturation.

Differential Diagnosis

It is imperative to distinguish a lactobezoar from:
* Necrotizing Enterocolitis (NEC)
* Hypertrophic Pyloric Stenosis
* Intestinal Volvulus
* Gastric Perforation


4. Standard Diagnostic Evaluation & Workup

The diagnosis of a lactobezoar is confirmed through a combination of clinical history and advanced imaging.

Diagnostic Imaging

  • Abdominal Radiography (X-ray): Often the first-line investigation. Findings typically reveal a large, soft-tissue density mass within the stomach, often outlined by a rim of air, creating a "gas-halo" effect.
  • Abdominal Ultrasound (The Gold Standard): Ultrasound is the preferred diagnostic modality. It provides high-resolution imaging of the stomach contents. A lactobezoar appears as a well-defined, heterogeneous, hyperechoic mass with posterior acoustic shadowing. It allows for the differentiation between solid masses and fluid-filled structures.
  • Upper Gastrointestinal (UGI) Series: May be used if the ultrasound is inconclusive or if there is a suspicion of complete obstruction or perforation.

Laboratory Assays

While there are no specific blood markers for a lactobezoar, laboratory testing is used to assess the systemic impact of the obstruction:
* Electrolyte Panel: To assess for dehydration and metabolic alkalosis (common with persistent vomiting).
* Complete Blood Count (CBC): To rule out sepsis or active inflammation.
* Blood Gas Analysis: To monitor for acidosis if the infant is hemodynamically unstable.


5. Therapeutic Interventions

Management is generally conservative, as most lactobezoars respond well to non-surgical intervention.

Conservative Management (First-Line)

  1. NPO Status: Immediate cessation of oral or enteral feedings to allow the stomach to rest and reduce further accumulation of curds.
  2. Gastric Lavage: Gentle irrigation of the stomach with warm saline or sterile water through a nasogastric tube can help break up the mass.
  3. Intravenous Fluid Resuscitation: To maintain electrolyte balance and hydration status while the infant is NPO.
  4. Dietary Modification: Once the bezoar is resolved, the clinical team should re-evaluate the infant’s formula. Transitioning to a pre-digested (hydrolyzed) formula or adjusting the caloric density is often necessary to prevent recurrence.

Surgical Intervention

Surgery is reserved for cases that fail conservative management or present with complications such as perforation or peritonitis.
* Gastrotomy: A surgical procedure to open the stomach and manually evacuate the lactobezoar.
* Endoscopic Removal: In specialized pediatric centers, endoscopic fragmentation and retrieval of the bezoar may be attempted using specialized snares or baskets, though this carries a higher risk of perforation in neonates.


6. Frequently Asked Questions (FAQ)

1. Is a lactobezoar the same as a hairball (trichobezoar)?
No. A lactobezoar is composed of milk curds, whereas a trichobezoar is composed of ingested hair. They are distinct in etiology and patient population.

2. Can breastfed infants develop a lactobezoar?
It is extremely rare. Lactobezoars are almost exclusively associated with infant formulas, particularly those that are highly concentrated or have high casein content.

3. What is the "gas-halo" sign?
This is a specific radiological appearance where a rim of air surrounds the solid mass of the lactobezoar within the stomach, often visible on a standard X-ray.

4. How long does it take for a lactobezoar to resolve?
With appropriate NPO status and gastric irrigation, most lactobezoars resolve within 24 to 72 hours.

5. Are there long-term complications?
If treated promptly, there are usually no long-term sequelae. If neglected, complications like gastric perforation can lead to long-term scarring or adhesion formation.

6. Should I stop the formula immediately if I suspect a lactobezoar?
Yes. If you suspect your infant has an obstruction, contact your pediatrician or go to the emergency department immediately. Do not offer more food.

7. Is surgery always required?
No. Surgery is a last resort. Conservative management via NPO status and fluid support is successful in the vast majority of cases.

8. Can a lactobezoar cause permanent damage to the stomach?
Rarely. However, if the mass causes significant pressure necrosis or ulceration, there may be a risk of temporary gastric wall thinning or perforation.

9. How can I prevent a lactobezoar in the future?
Ensure formula is prepared exactly according to the manufacturer’s instructions. Do not "over-concentrate" the formula to increase caloric intake without direct medical supervision.

10. What is the gold standard for diagnosing a lactobezoar?
Abdominal ultrasound is considered the gold standard due to its ability to visualize the internal structure of the mass without exposing the infant to ionizing radiation.


Disclaimer: This guide is for educational purposes for healthcare professionals and patients. It does not replace professional medical advice, diagnosis, or treatment. Always seek the advice of your physician with any questions regarding a medical condition.

Related Clinical Integration

In the clinical management of lactobezoars, a structured approach is essential to facilitate the safe breakdown and removal of gastric milk curds. When conservative management—such as temporary cessation of enteral feeding and fluid resuscitation—proves insufficient, pharmacological intervention with N-acetylcysteine / ن-أسيتيل سيستئين Standard may be considered to assist in the mucolytic dissolution of the bezoar mass. Should the obstruction persist or result in significant gastric distension, clinicians must be prepared to perform gastric lavage or aspiration, utilizing a properly sized Suction catheter / قسطرة الشفط to clear the fragmented debris while maintaining airway protection and hemodynamic stability.

Treatment & Management Options

Recommended Medications

Share this guide: